ENTITY

Xunfei Healthcare Technology (XHT HK)

15
Analysis
Health Care • China

•11 Nov 2024 15:19

CMCDI (133 HK)'s EGM Double-Header

If shareholders want exposure to CMB and iFlytek, they can buy directly, as opposed to a heavily discounted illiquid name. CMCDI's large NAV...

Logo
503 Views
Share
•22 Oct 2024 16:20

CMCDI (133 HK): Concessions Don't Go Far Enough

If small, illiquid names, with a activism angle are your bent, get involved in this deep valued closed-end fund around here.

Logo
585 Views
Share
•02 Oct 2024 15:00

CMCDI (133 HK)'s Proposals Light On Detail

If small, illiquid names, with a activism angle are your bag, get involved. Expect the investment management fee vote later this year to get voted...

Logo
508 Views
Share
•28 Jun 2024 07:00

CMCDI (133 HK): Buybacks And Management Fees Into Focus

CMCDI remains cheap. I think a buyback is a distinct possibility. And changes to the management agreement have to occur within the next few months.

Logo
481 Views
Share
•21 Jun 2024 11:58

CMCDI (133 HK): Kan Re-Elected. But Only Just

CMCDI remains cheap. Argyle is still buying. If small, illiquid names, with a activism angle are your forte, get involved.

Logo
798 Views
Share
x